Niranjan Rao

A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response

Keith W. Pratz, Jörge E. Cortes, Gail J. Roboz et al. · Blood · 2008 · 182 citations · Full text

The Pharmacokinetics of Escitalopram After Oral and Intravenous Administration of Single and Multiple Doses to Healthy Subjects

Birgitte Søgaard, H. Mengel, Niranjan Rao et al. · The Journal of Clinical Pharmacology · 2005 · 138 citations

Healthy Subjects, Intravenous Administration, Multiple Doses +11

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

Ana B. Pavel, Teresa Song, Hyun Je Kim et al. · Journal of Allergy and Clinical Immunology · 2019 · 136 citations

Inflammation, Atopic Dermatitis, Immunology +5

The oral Janus kinase/spleen tyrosine kinase inhibitor<scp>ASN</scp>002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study

Robert Bissonnette, Catherine Maari, Seth Forman et al. · British Journal of Dermatology · 2019 · 125 citations · Full text

Lack of Pharmacokinetic or Pharmacodynamic Interaction Between Memantine and Donepezil

Antonia Periclou, Daniel Ventura, Tyler Sherman et al. · Annals of Pharmacotherapy · 2004 · 79 citations